![]() | |
Clinical data | |
---|---|
Pronunciation | a" va trom' boe pag |
Trade names | Doptelet |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a618032 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C29H34Cl2N6O3S2 |
Molar mass | 649.65 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. [8] [9] It was approved for medical use in the United States in May 2018, [10] [11] the European Union in June 2019, [7] and Australia in January 2023. [1]
It acts as a thrombopoietin receptor agonist. [12]
![]() | |
Clinical data | |
---|---|
Pronunciation | a" va trom' boe pag |
Trade names | Doptelet |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a618032 |
License data |
|
Pregnancy category |
|
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C29H34Cl2N6O3S2 |
Molar mass | 649.65 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure. [8] [9] It was approved for medical use in the United States in May 2018, [10] [11] the European Union in June 2019, [7] and Australia in January 2023. [1]
It acts as a thrombopoietin receptor agonist. [12]